Medications

Antibiotics, corticosteroids beneficial in COPD exacerbations

(HealthDay)—For adults with exacerbation of chronic obstructive pulmonary disease (COPD), antibiotics and systemic corticosteroids are associated with less treatment failure, according to a review published online Feb. ...

Diseases, Conditions, Syndromes

Admissions, deaths for COPD vary by season

(HealthDay)—There is dramatic seasonal variation in rates of admissions for chronic obstructive pulmonary disease (COPD) exacerbation, according to a study presented at CHEST 2019, the annual meeting of the American College ...

Diseases, Conditions, Syndromes

Beta-blocker trial does not reduce risks for COPD patients

New research from scientists at the University of Alabama at Birmingham published in the New England Journal of Medicine has found that beta-blockers used in a clinical trial for patients with chronic obstructive pulmonary ...

Health

Telehealth pulmonary rehabilitation reduces 30-day readmissions

New research published in the American Journal of Respiratory and Critical Care Medicine from the University of Alabama at Birmingham shows that video telehealth pulmonary rehabilitation interventions reduce 30-day all-cause ...

Diseases, Conditions, Syndromes

Small reduction in lung function with Tx de-escalation in COPD

(HealthDay)—A de-escalation from triple therapy to indacaterol/glycopyrronium may lead to a small reduction in lung function in non-frequently exacerbating patients with chronic obstructive pulmonary disease (COPD) but ...

page 3 from 14